Evaluation of DNA repair inhibition by antitumor or antibiotic drugs using a chemiluminescence microplate assay

Carcinogenesis. 1997 Dec;18(12):2441-5. doi: 10.1093/carcin/18.12.2441.

Abstract

A recently derived in vitro chemiluminescence assay (Salles et al. [1995] Anal. Biochem., 232, 37-42) has been used to investigate the effects of a panel of twenty-two anticancer drugs and certain antibiotics on the excision repair activity of cell-free extracts from the human cell line, HeLa. This methodology, termed the 3D (Damaged DNA Detection) assay, based on the in vitro excision repair assay previously developed (Wood et al. [1988] Cell, 53, 97-106) has provided data indicating definite in vitro inhibition of DNA repair by actinomycin D, aphidicolin, doxorubicin, distamycin A and mithramycin A. This assay therefore offers the potential for identifying agents with the ability to inhibit DNA repair.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Antineoplastic Agents / pharmacology*
  • DNA Repair / drug effects*
  • DNA, Bacterial / drug effects
  • DNA, Bacterial / radiation effects
  • Dose-Response Relationship, Drug
  • HeLa Cells
  • Humans
  • Luminescent Measurements
  • Methods
  • Plasmids
  • Ultraviolet Rays

Substances

  • Anti-Bacterial Agents
  • Antineoplastic Agents
  • DNA, Bacterial